Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 -0.0346232179226069 -0.0387780040733198
Stock impact report

BrainStorm Cell +4% premarket on $1.5M grant [Seeking Alpha]

Brainstorm Cell Therapeutics Inc. (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com
Company Research Source: Seeking Alpha
BrainStorm Cell Therapeutics (NASDAQ:BCLIawardedThe grant will enable continued development of advanced cellular manufacturing capabilities, MSC-derived exosomes, and expansion of therapeutic pipeline in neurodegenerative disorders.BrainStorm has to pay mid-single digit royalties to the IIA based on sales of the products, up to a total of the cumulative amount of IIA grants received plus accumulated interest.Shares are up4% Show less Read more
Impact Snapshot
Event Time:
BCLI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BCLI alerts

from News Quantified
Opt-in for
BCLI alerts

from News Quantified